ES2087323T3 - Metodo para producir peptidos exentos de cisteina. - Google Patents

Metodo para producir peptidos exentos de cisteina.

Info

Publication number
ES2087323T3
ES2087323T3 ES92102543T ES92102543T ES2087323T3 ES 2087323 T3 ES2087323 T3 ES 2087323T3 ES 92102543 T ES92102543 T ES 92102543T ES 92102543 T ES92102543 T ES 92102543T ES 2087323 T3 ES2087323 T3 ES 2087323T3
Authority
ES
Spain
Prior art keywords
cysteine
free peptides
producing cysteine
producing
terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92102543T
Other languages
English (en)
Inventor
Osamu Nishimura
Masato Kuriyama
Noboyuki Koyama
Tsunehiko Fukuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27284805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2087323(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2087323T3 publication Critical patent/ES2087323T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PRODUCE UN PEPTIDO LIBRE DE CISTEINA PRODUCIENDO UNA PROTEINA FUSIONADA QUE CONSTA DE UNA PROTEINA QUE TIENE CISTEINA COMO SU TERMINAL-N Y UN PEPTIDO LIBRE DE CISTEINA LIGADO AL TERMINAL-N Y SUBSIGUIENTEMENTE SOMETER LA PROTEINA FUSIONADA A UNA REACCION PARA DESDOBLAR LA UNION PEPTIDA.
ES92102543T 1991-02-19 1992-02-15 Metodo para producir peptidos exentos de cisteina. Expired - Lifetime ES2087323T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2484191 1991-02-19
JP27143891 1991-10-18
JP27772491 1991-10-24

Publications (1)

Publication Number Publication Date
ES2087323T3 true ES2087323T3 (es) 1996-07-16

Family

ID=27284805

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92102543T Expired - Lifetime ES2087323T3 (es) 1991-02-19 1992-02-15 Metodo para producir peptidos exentos de cisteina.

Country Status (7)

Country Link
US (2) US5861284A (es)
EP (1) EP0499990B1 (es)
KR (1) KR100249534B1 (es)
AT (1) ATE138102T1 (es)
CA (1) CA2061382C (es)
DE (1) DE69210645T2 (es)
ES (1) ES2087323T3 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE138102T1 (de) 1991-02-19 1996-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von cysteinfreien peptiden
US5563122A (en) * 1991-12-09 1996-10-08 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
SK155694A3 (en) * 1992-06-15 1995-05-10 Pfizer Glucagon-like peptide, insulinotropin derivatives, method of their preparation, pharmaceutical agent containing and using these matters
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
AU4415796A (en) * 1994-12-07 1996-06-26 Bionebraska, Inc. Production of c-terminal amidated peptides from recombinant protein constructs
WO1997029180A1 (en) * 1996-02-06 1997-08-14 Eli Lilly And Company Diabetes therapy
EP0887417A3 (en) 1997-06-27 1999-01-13 Takeda Chemical Industries, Ltd. Method of producing a 19P2 ligand by cleavage of a fusion protein containing it
KR100230578B1 (ko) * 1997-07-25 1999-12-01 허영섭 포스포리불로키나제를 융합파트너로 이용하는 재조합 인간 부갑상선호르몬의 발현벡터
EP1138772A4 (en) * 1998-12-11 2005-04-06 Takeda Chemical Industries Ltd PROCESS FOR THE PRODUCTION OF APELINE
WO2001044469A1 (fr) * 1999-12-17 2001-06-21 Takeda Chemical Industries, Ltd. PROCEDE DE PRODUCTION DE PEPTIDE KiSS-1
US6641820B1 (en) 2000-01-19 2003-11-04 Allergan, Inc. Clostridial toxin derivatives and methods to treat pain
US7138127B1 (en) 2000-01-19 2006-11-21 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
US6500436B2 (en) 2000-01-19 2002-12-31 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
KR100407792B1 (ko) * 2000-08-02 2003-12-01 한국생명공학연구원 인간 글루카곤 유사펩타이드를 융합파트너로 이용한재조합 단백질의 제조방법
AU2002221067A1 (en) * 2000-12-07 2002-06-18 Takeda Chemical Industries Ltd. Process for producing rfrp
EP1466976A4 (en) * 2002-01-11 2005-11-09 Takeda Pharmaceutical PROCESS FOR PREPARING KISS-1 PEPTIDES
AU2003233286A1 (en) * 2002-05-16 2003-12-02 Theratechnologies Inc. Pth derivatives resistant to skin proteases
JP2006501820A (ja) * 2002-09-06 2006-01-19 バイエル・フアーマシユーチカルズ・コーポレーシヨン 修飾ｇｌｐ−１受容体アゴニストおよびそれらの薬理学的使用法
CA2498319A1 (en) * 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US20060198894A1 (en) * 2002-10-29 2006-09-07 Johanna Bentz Stabilized, solid-state polypeptide particles
HRP20120315T1 (hr) 2003-11-21 2012-05-31 Nps Pharmaceuticals Proizvodnja peptida 2 nalik glukagonu i analoga
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
RS51319B (sr) * 2005-09-22 2010-12-31 Biocompatibles Uk Limited GLP-l (GLUKAGON-LIKE PEPTID-l) FUZIONI POLIPEPTIDI SA POVEĆANOM OTPORNOSTI NA PEPTIDAZE
EP1854455B1 (en) * 2006-05-10 2009-10-07 Biocompatibles UK Limited Spherical microcapsules comprising GLP-1 peptides, their production and use
JP5004165B2 (ja) * 2006-10-10 2012-08-22 独立行政法人産業技術総合研究所 タンパク質の配向制御固定化に適したタンパク質
EP1972349A1 (en) * 2007-03-21 2008-09-24 Biocompatibles UK Limited GLP-1 fusion peptides conjugated to polymer(s), their production and use
EP1975176A1 (en) * 2007-03-27 2008-10-01 Biocompatibles UK Limited Novel glp-1 fusion peptides, their production and use
BRPI0819212A2 (pt) * 2007-10-23 2015-06-16 Allergan Inc Métodos de tratamento de inflamação neurogênica crônica usando toxinas modificadas de clostrídio
EP2163243A1 (en) * 2008-09-12 2010-03-17 Biocompatibles UK Limited Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof
JP5738027B2 (ja) 2010-03-30 2015-06-17 キヤノン株式会社 質量分析法
US8921599B2 (en) 2010-10-27 2014-12-30 Emory University Processes for forming amide bonds and compositions related thereto
EP4277917A4 (en) 2021-01-14 2024-06-19 Biocatalyst LLC Compositions and methods for peptide production
WO2025247862A1 (en) * 2024-05-27 2025-12-04 Numaferm Gmbh Methods for the c-terminal modification of (poly)peptides
EP4737471A1 (en) * 2024-10-29 2026-05-06 NUMAFERM GmbH Methods for the c-terminal modification of (poly)peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
GB8308483D0 (en) * 1983-03-28 1983-05-05 Health Lab Service Board Secretion of gene products
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
JP2599591B2 (ja) * 1987-04-28 1997-04-09 キヤノン株式会社 電子放出素子特性測定装置
US5426036A (en) * 1987-05-05 1995-06-20 Hoechst Aktiengesellschaft Processes for the preparation of foreign proteins in streptomycetes
EP0293158A3 (en) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
DE3725320A1 (de) * 1987-07-30 1989-02-09 Biotechnolog Forschung Gmbh Expressionsvektoren und verfahren unter deren verwendung zur gewinnung von cro/ss-galaktosidase/pth-fusionsproteinen und von pth
DE69001248T2 (de) * 1989-05-04 1993-10-14 Genentech Inc Verfahren und zusammensetzungen zur isolation von menschlichem relaxin.
ATE138102T1 (de) * 1991-02-19 1996-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von cysteinfreien peptiden

Also Published As

Publication number Publication date
EP0499990A2 (en) 1992-08-26
EP0499990B1 (en) 1996-05-15
EP0499990A3 (en) 1993-03-17
KR100249534B1 (ko) 2000-03-15
ATE138102T1 (de) 1996-06-15
DE69210645T2 (de) 1996-11-28
KR920016463A (ko) 1992-09-24
US5861284A (en) 1999-01-19
CA2061382C (en) 2003-02-18
US6287806B1 (en) 2001-09-11
DE69210645D1 (de) 1996-06-20
CA2061382A1 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
EP0499990A3 (en) Method for producing cysteine-free peptides
ATE280227T1 (de) Epitope von stress proteinen
DK1752465T3 (da) Lineær VH-CH1-VH-CH1 tung-kæde antistof-fragment
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
ATE174628T1 (de) Expression rekombinanter fusionsproteine in attenuierten bakterien
ATE305509T1 (de) Ozean fisch antifrost peptide als nahrungsmittelzusatz
ES2124295T3 (es) Expresion y purificacion de factor tisular soluble recombinante.
HU902697D0 (en) Process for the enzymatic removal of the n-terminal sequence of proteins
AU676859B2 (en) Synthetic peptides, antibodies against them and their use
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
WO1995003405A3 (en) Enzymatic method for modification of recombinant polypeptides
FI892688L (fi) Menetelmä terapeuttisesti käyttökelpoisten oligopeptidien valmistamiseksi, joissa on proliinille analogisia syklisiä aminohappoja
NO900758L (no) Fremgangsmaate for fremstilling av hybridprotein.
AU3825389A (en) Hcg peptides for use in antibody purification procedures
NO913078L (no) Oekt proteinproduksjon i dyr.
DE3882154D1 (de) Verfahren zur herstellung des pres 1/s2/s-hepatitis-b-antigens aus hefe.
DE58901435D1 (de) Verfahren zur herstellung von dipeptiden mit n-terminalen nichtproteinogenen aminosaeuren.
EP0350218A3 (en) Monoclonal antibodies recognizing gamma atrial natriuretic polypeptide, hybridomas producing such antibodies, and their preparation and use
DK0779297T3 (da) Antigene peptider med glycinsubstitutioner
ES2049021T3 (es) Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion.
FI891652A7 (fi) Menetelmä proteiinien valmistamiseksi, joiden N-terminaali alkaa proliinilla
ES2061760T3 (es) Antibiotico antitumoral kedarcidina.
NO843750L (no) Immuninterferon og fremgangsmaate ved fremstilling derav
KR950018050A (ko) 사람 글리센틴의 제조방법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0499990

Country of ref document: ES